Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed or Refractory Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01164709
What this trial is testing

Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMature T-cell and Nk-cell Neoplasms+1 more
Swiss Cancer Institute 18
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04809467
What this trial is testing

A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic LeukemiaNon Hodgkin Lymphoma
Incyte Corporation 54
Early research (Phase 1)Active Not RecruitingNCT04526834
What this trial is testing

Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaPeripheral T Cell LymphomaExtranodal NK/T-cell Lymphoma+2 more
Tessa Therapeutics 21
Early research (Phase 1)Study completedNCT03483688
What this trial is testing

A PhaseⅠb Study Evaluating Safety and Efficacy of C-CAR011 Treatment in B- NHL Subjects

Who this might be right for
B-cell Non-Hodgkin Lymphoma
Peking Union Medical College Hospital 6
Testing effectiveness (Phase 2)Study completedNCT03505996
What this trial is testing

CS1001 in Subjects With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
CStone Pharmaceuticals 82
Testing effectiveness (Phase 2)Ended earlyNCT00667017
What this trial is testing

RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
University of Texas Southwestern Medical Center 1
Testing effectiveness (Phase 2)Ended earlyNCT00086840
What this trial is testing

CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Hodgkin LymphomaRefractory Chronic Lymphocytic Leukemia
National Cancer Institute (NCI) 60
Early research (Phase 1)Ended earlyNCT01300793
What this trial is testing

Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide

Who this might be right for
Non-Hodgkin's LymphomaB-cell Lymphoma
University of California, San Francisco 6
Testing effectiveness (Phase 2)Ended earlyNCT01944943
What this trial is testing

Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
Diffuse Large B-cell LymphomaIndolent Non-hodgkin LymphomaPrimary Central Nervous System Lymphoma+1 more
The Lymphoma Academic Research Organisation 31
Testing effectiveness (Phase 2)UnknownNCT01307592
What this trial is testing

Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Auxilio Mutuo Cancer Center 70
Large-scale testing (Phase 3)Active Not RecruitingNCT05171647
What this trial is testing

A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Hoffmann-La Roche 208
Testing effectiveness (Phase 2)UnknownNCT05805943
What this trial is testing

Study of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's Lymphoma

Who this might be right for
CD20-positive B-cell Non-Hodgkin's Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 154
Not applicableTemporarily pausedNCT03229876
What this trial is testing

Safety and Efficacy Evaluation of CD19-UCART

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Non Hodgkin Lymphoma (NHL)
Bioray Laboratories 20
Early research (Phase 1)UnknownNCT04693676
What this trial is testing

C-CAR039 Treatment in Subjects With r/r NHL Subjects Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's B-cell Lymphoma
First Affiliated Hospital of Zhejiang University 17
Early research (Phase 1)Looking for participantsNCT07603479
What this trial is testing

JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Who this might be right for
MalignanciesSolid Malignant TumorNHL (Non-Hodgkin Lymphoma)+1 more
Jecho Biopharmaceuticals Co., Ltd. 14
Testing effectiveness (Phase 2)Study completedNCT03526250
What this trial is testing

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more
National Cancer Institute (NCI) 23
Early research (Phase 1)Looking for participantsNCT05418088
What this trial is testing

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Who this might be right for
Recurrent Acute Lymphoblastic LeukemiaRecurrent B Acute Lymphoblastic LeukemiaRecurrent B-Cell Prolymphocytic Leukemia+15 more
Sumithira Vasu 54
Early research (Phase 1)UnknownNCT00004086
What this trial is testing

Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer

Who this might be right for
LeukemiaLymphoma
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Testing effectiveness (Phase 2)Study completedNCT01939327
What this trial is testing

Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Institut Paoli-Calmettes 34
Next Page